188 related articles for article (PubMed ID: 17312326)
1. Public preferences and organized interests in health policy: state pharmacy assistance programs as innovations.
Gray V; Lowery D; Godwin EK
J Health Polit Policy Law; 2007 Feb; 32(1):89-129. PubMed ID: 17312326
[TBL] [Abstract][Full Text] [Related]
2. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
Thomas CP; Sussman J; ;
Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
[TBL] [Abstract][Full Text] [Related]
3. Reforming patient assistance programs: perfect world meets real world.
Weinberg M
Health Aff (Millwood); 2009; 28(3):839-42. PubMed ID: 19414895
[TBL] [Abstract][Full Text] [Related]
4. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
5. Bridging the gap: state and private industry response to the lack of a Medicare outpatient prescription drug benefit.
Goldstein WC; Peterson KA
Manag Care Interface; 2002 Jun; 15(6):55-8. PubMed ID: 12087608
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceuticals and medical devices: State Pharmaceutical Assistance Programs (SPAPs). End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-15. PubMed ID: 18345559
[No Abstract] [Full Text] [Related]
7. Prescription drug benefits: the legal battle begins.
Benjamin GC; Cashiola C
Physician Exec; 2002; 28(6):60-1. PubMed ID: 12448147
[No Abstract] [Full Text] [Related]
8. State pharmaceutical assistance for the elderly and disabled: planning issues for program and nonprogram states.
Hermanson S; Lago D; Smyer MA
J Aging Soc Policy; 1991; 3(3):71-81. PubMed ID: 10186792
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
[No Abstract] [Full Text] [Related]
10. The political management of managed care: explaining variations in state health maintenance organization regulations.
Gray V; Lowery D; Godwin EK
J Health Polit Policy Law; 2007 Jun; 32(3):457-95. PubMed ID: 17519474
[TBL] [Abstract][Full Text] [Related]
11. Interest groups and state Medicaid drug programs.
Pracht EE; Moore WJ
J Health Polit Policy Law; 2003 Feb; 28(1):9-39. PubMed ID: 12705416
[TBL] [Abstract][Full Text] [Related]
12. Design of a pharmacy benefit of low-income seniors: lessons from state pharmacy assistance programs.
AcademyHealth, Health Care Financing & Organization
Find Brief; 2007 Jan; 10(1):1-4. PubMed ID: 17302010
[No Abstract] [Full Text] [Related]
13. State Medicaid managed care enrollment: understanding the political calculus that drives Medicaid managed care reforms.
Pracht EE
J Health Polit Policy Law; 2007 Aug; 32(4):685-731. PubMed ID: 17639017
[TBL] [Abstract][Full Text] [Related]
14. State variations in the out-of-pocket spending burden for outpatient mental health treatment.
Zuvekas SH; Meyerhoefer CD
Health Aff (Millwood); 2009; 28(3):713-22. PubMed ID: 19414879
[TBL] [Abstract][Full Text] [Related]
15. Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment.
Grootendorst P
Can J Clin Pharmacol; 2002; 9(2):79-99. PubMed ID: 12172588
[TBL] [Abstract][Full Text] [Related]
16. Pharmacy benefit management contracting: an assessment from a recent public sector procurement experience.
Bae JP; Justice PG
J Health Care Finance; 2002; 29(1):49-56. PubMed ID: 12199494
[TBL] [Abstract][Full Text] [Related]
17. Public and private health initiatives in Kansas.
Fonner E
J Health Care Finance; 1998; 25(1):35-45. PubMed ID: 9718510
[TBL] [Abstract][Full Text] [Related]
18. Controlling pharmacy costs in the NC Medicaid program.
Dobson LA
N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
[No Abstract] [Full Text] [Related]
19. Stepping up to bat: states take the lead on health policy.
Sorian R
J Am Health Policy; 1992; 2(3):14a-16a. PubMed ID: 10118221
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
